Conformal irradiation of the prostate: estimating long-term rectal bleeding risk using dose-volume histograms.

PURPOSE Dose-volume histograms (DVHs) may be very useful tools for estimating probability of normal tissue complications (NTCP), but there is not yet an agreed upon method for their analysis. This study introduces a statistical method of aggregating and analyzing primary data from DVHs and associated outcomes. It explores the dose-volume relationship for NTCP of the rectum, using long-term data on rectal wall bleeding following prostatic irradiation. METHODS AND MATERIALS Previously published data were reviewed and updated on 41 patients with Stages T3 and T4 prostatic carcinoma treated with photons followed by perineal proton boost, including dose-volume histograms (DVHs) of each patient's anterior rectal wall and data on the occurrence of postirradiation rectal bleeding (minimum FU > 4 years). Logistic regression was used to test whether some individual combination of dose and volume irradiated might best separate the DVHs into categories of high or low risk for rectal bleeding. Further analysis explored whether a group of such dose-volume combinations might be superior in predicting complication risk. These results were compared with results of the "critical volume model," a mathematical model based on assumptions of underlying radiobiological interactions. RESULTS Ten of the 128 tested dose-volume combinations proved to be "statistically significant combinations" (SSCs) distinguishing between bleeders (14 out of 41) and nonbleeders (27 out of 41), ranging contiguously between 60 CGE (Cobalt Gray Equivalent) to 70% of the anterior rectal wall and 75 CGE to 30%. Calculated odds ratios for each SSC were not significantly different across the individual SSCs; however, analysis combining SSCs allowed segregation of DVHs into three risk groups: low, moderate, and high. Estimates of probabilities of normal tissue complications (NTCPs) based on these risk groups correlated strongly with observed data (p = 0.003) and with biomathematical model-generated NTCPs. CONCLUSIONS There is a dose-volume relationship for rectal mucosal bleeding in the region between 60 and 75 CGE; therefore, efforts to spare rectal wall volume using improved treatment planning and delivery techniques are important. Stratifying dose-volume histograms (DVHs) into risk groups, as done in this study, represents a useful means of analyzing empirical data as a function of hetereogeneous dose distributions. Modeling efforts may extend these results to more heterogeneous treatment techniques. Such analysis of DVH data may allow practicing clinicians to better assess the risk of various treatments, fields, or doses, when caring for an individual patient.

[1]  M. Zelefsky,et al.  Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy. , 1994, International journal of radiation oncology, biology, physics.

[2]  S. Skates,et al.  A dose response analysis of injury to cranial nerves and/or nuclei following proton beam radiation therapy. , 1992, International journal of radiation oncology, biology, physics.

[3]  S. Leibel,et al.  Local control is associated with decreased distant failure in early stage carcinoma of the prostate , 1989 .

[4]  R. Mohan,et al.  Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. , 1991, International journal of radiation oncology, biology, physics.

[5]  C. Perez,et al.  Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostate. , 1993, International journal of radiation oncology, biology, physics.

[6]  P. Schmidt,et al.  Limited-Dependent and Qualitative Variables in Econometrics. , 1984 .

[7]  R K Ten Haken,et al.  Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. , 1994, International journal of radiation oncology, biology, physics.

[8]  Marc L. Kessler,et al.  The use of 3-D dose volume analysis to predict radiation hepatitis. , 1991 .

[9]  P. Kantoff,et al.  Rate of relapse following treatment for localized prostate cancer: a critical analysis of retrospective reports. , 1994, International journal of radiation oncology, biology, physics.

[10]  T. Schultheiss,et al.  Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate. , 1995, International journal of radiation oncology, biology, physics.

[11]  M Goitein,et al.  Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  R Mohan,et al.  Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study. , 1994, International journal of radiation oncology, biology, physics.

[13]  L. Verhey,et al.  Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. , 1995, International journal of radiation oncology, biology, physics.

[14]  M Goitein,et al.  Proton radiation as boost therapy for localized prostatic carcinoma. , 1979, JAMA.

[15]  G E Hanks,et al.  Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques: a reduction in acute morbidity. , 1992, International journal of radiation oncology, biology, physics.

[16]  M Goitein,et al.  Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma. , 1993, International journal of radiation oncology, biology, physics.

[17]  H. Sandler,et al.  Potential improvement in the results of irradiation for prostate carcinoma using improved dose distribution. , 1992, International journal of radiation oncology, biology, physics.

[18]  A. Zietman,et al.  Treatment related sequelae following external beam radiation for prostate cancer: a review with an update in patients with stages T1 and T2 tumor. , 1994, The Journal of urology.

[19]  T L Phillips Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose escalation study. , 1994, International journal of radiation oncology, biology, physics.

[20]  A. Niemierko,et al.  Modeling of normal tissue response to radiation: the critical volume model. , 1993, International journal of radiation oncology, biology, physics.

[21]  A B Wolbarst,et al.  Optimization of radiation therapy, III: A method of assessing complication probabilities from dose-volume histograms. , 1987, International journal of radiation oncology, biology, physics.

[22]  C. Burman,et al.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.

[23]  C B Begg,et al.  The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. , 1991, International journal of radiation oncology, biology, physics.

[24]  H. Sandler,et al.  Three dimensional conformal radiotherapy for the treatment of prostate cancer: low risk of chronic rectal morbidity observed in a large series of patients. , 1995, International journal of radiation oncology, biology, physics.